|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Deferred Offering Costs | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | |||||||
| Prepaid expenses | |||||||
| Marketable securities held in Trust Account | |||||||
| Total current assets | |||||||
| Marketable securities held in Trust Account | |||||||
| Non-current prepaid expenses | |||||||
| Total Assets | |||||||
| Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders' Equity (Deficit) | |||||||
| Current liabilities: | |||||||
| Accounts payable | |||||||
| Accrued expenses | |||||||
| Note payable - related party | |||||||
| Due to affiliates | |||||||
| Accrued professional fees | |||||||
| Accrued offering costs | |||||||
| Deferred underwriting commissions | |||||||
| Total current liabilities | |||||||
| Deferred underwriting commissions | |||||||
| Total liabilities | |||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 40,000,000 shares subject to possible redemption at $10.00 per share at accreted value | |||||||
| Shareholders' Equity (Deficit): | |||||||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding | |||||||
| Ordinary shares, $0.0001 par value | |||||||
| Class A Ordinary Shares | |||||||
| Class B Ordinary Shares | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total shareholders' equity (deficit) | |||||||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders' Equity (Deficit) |
Loading...